1.Management of children after renal transplantation: highlights for general pediatricians.
Keith K LAU ; Lucy GIGLIA ; Howard CHAN ; Anthony K CHAN
Chinese Journal of Contemporary Pediatrics 2012;14(2):81-88
The number of children undergoing successful renal transplantations has been increasing steadily and as a result, general pediatricians are now more likely to encounter children with a kidney allograft in their practice. Although the medical care immediately after transplantation is mostly provided by transplant teams, more and more outpatient care will eventually be performed at the patient's local community. Medical care from general pediatricians is particularly important, especially for children who are residing far from transplant centers. As these children require prolong immunosuppressive therapies and are susceptible to various specific clinical problems, it is imperative for their primary care providers and pediatricians to be knowledgeable about their specific needs and be competent in providing care. This article highlights the roles and common practice related issues that pertain to general pediatricians in the care of pediatric renal allograft recipients.
Child
;
Humans
;
Immunosuppressive Agents
;
therapeutic use
;
Kidney Transplantation
;
adverse effects
;
psychology
;
Pediatrics
;
Vaccination
2.Thrombotic thrombocytopenic purpura in pediatric patients.
Melanie STEELE ; Howard H W CHEN ; Jeremy STEELE ; Anthony K C CHAN ; Keith K LAU
Chinese Journal of Contemporary Pediatrics 2012;14(11):803-810
Although thrombotic thrombocytopenic purpura (TTP) is rarely seen in pediatric patients, failure to recognize this condition often leads to severe consequences and poor outcomes. Classic features of TTP include thrombocytopenia, microangiopathic hemolytic anemia, acute kidney injury, fever, and central nervous system involvement. However, patients suffering from this condition may not present with all of the symptoms simultaneously. Therefore, it is of utmost importance for healthcare providers to have a high index of suspicion. Laboratory investigations may reveal the presence of schistocytes on peripheral blood smear, negative Coombs test, high lactate dehydrogenase levels and severely low platelet counts. The etiology of TTP is mainly due to insufficient cleavage of the large multimers of von Willebrand factor (vWF) secondary to decreased activity of ADAMTS13 (a disintegrin and metalloprotease with Thrombospondin type 1 repeats, member 13). TTP can be broadly classified into familial TTP (Upshaw Schulman syndrome) and non-familial TTP. Familial TTP is due to a congenital deficiency of ADAMTS13. Its mainstay of therapy is initiation of plasmapheresis during the acute phase, followed by regular fresh frozen plasma (FFP) infusions. Alternatively, non-familial TTP is due to a decrease in ADAMTS13 activity secondary to the presence of anti-ADAMTS13 antibodies. Once again, the primary treatment is plasmapheresis; however, recent anecdotal data also supports the use of rituximab in select cases.
ADAM Proteins
;
genetics
;
ADAMTS13 Protein
;
Antibodies, Monoclonal, Murine-Derived
;
therapeutic use
;
Child
;
Humans
;
Plasmapheresis
;
Purpura, Thrombotic Thrombocytopenic
;
etiology
;
therapy
;
Rituximab
3.My mother is looking blue
Howard Tat Chun Chan ; Anselm Wang Hei Hui ; Colin Graham ; Joseph Walline
World Journal of Emergency Medicine 2019;10(4):251-252
A 76-year-old Chinese female presented by ambulance to the Emergency Department complaining of dizziness, headache and fatigue. Her son claimed that the patient “turned blue” three hours prior to onset of the patient’s symptoms. Paramedics noted the patient’s SpO2 was 83% on room air with no improvement with a non- rebreather mask. Past medical history was significant for diabetes and hypertension. Family, social and medication history were non-contributory. Patient denied ingestion of any traditional Chinese medicines but did have some choy sum (a variety of green vegetable) for lunch five hours prior to arrival. On examination, the patient appeared agitated, but alert. Purple lips and fingers were noted (Figure 1). Physical examination: heart rate 55 beats/minute, pulse oximetry 87%, respiratory rate 16 breaths/minute, blood pressure 143/51 mmHg. Bedside investigations: chest X-ray (clear lung fields and cardiomegaly); ECG (sinus rhythm, slight bradycardia at 53 beats/minute); hemoglobin 9.3 g/dL; glucose 10.9 mmol/L (196.2 mg/dL).
4.The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019
In-Cheol KIM ; Jin Eun SONG ; Hee Jung LEE ; Jeong-Ho PARK ; Miri HYUN ; Ji Yeon LEE ; Hyun Ah KIM ; Yong Shik KWON ; Jae Seok PARK ; Jong-Chan YOUN ; Jongmin HWANG ; Cheol Hyun LEE ; Yun-Kyeong CHO ; Hyoung-Seob PARK ; Hyuck-Jun YOON ; Chang-Wook NAM ; Seongwook HAN ; Seung-Ho HUR ; Howard J. EISEN ; Hyungseop KIM
Journal of Korean Medical Science 2020;35(39):e349-
Background:
s: The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has spread worldwide. Cardiac injury after SARS-CoV-2 infection is a major concern. The present study investigated impact of the biomarkers indicating cardiac injury in coronavirus disease 2019 (COVID-19) on patients' outcomes.
Methods:
This study enrolled patients who were confirmed to have COVID-19 and admitted at a tertiary university referral hospital between February 19, 2020 and March 15, 2020. Cardiac injury was defined as an abnormality in one of the following result markers: 1) myocardial damage marker (creatine kinase-MB or troponin-I), 2) heart failure marker (N-terminal-pro B-type natriuretic peptide), and 3) electrical abnormality marker (electrocardiography). The relationship between each cardiac injury marker and mortality was evaluated. Survival analysis of mortality according to the scoring by numbers of cardiac injury markers was also performed.
Results:
A total of 38 patients with COVID-19 were enrolled. Twenty-two patients (57.9%) had at least one of cardiac injury markers. The patients with cardiac injuries were older (69.6 ± 14.9 vs. 58.6 ± 13.9 years old, P = 0.026), and were more male (59.1% vs. 18.8%, P = 0.013).They showed lower initial oxygen saturation (92.8 vs. 97.1%, P = 0.002) and a trend toward higher mortality (27.3 vs. 6.3%, P = 0.099). The increased number of cardiac injury markers was significantly related to a higher incidence of in-hospital mortality which was also evidenced by Kaplan-Meier survival analysis (P = 0.008).
Conclusion
The increased number of cardiac injury markers is related to in-hospital mortality in patients with COVID-19.